Immune Monitoring in Sensitized Patients at Risk of Rejection

Completed

Conditions studied: Kidney Failure

In brief

The purpose of this study is to test the effect of anti-rejection medications on your immune system

Key facts

Study ID

NCT03794817

Run by

University of California, San Francisco

People needed

112

Starts

2015-08-20

Expected to finish

2017-09-08

Last updated by the study team

2019-01-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older able to consent
• No history of HIV, hepatitis C and active hepatitis B infection
• cPRA ≥ 50%

You may not qualify if…

• Patients on Coumadin
• Human Leukocyte antigen (HLA) identical donor recipient patients

Where it is running

• University of California San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.